Genprex Inc GNPX

NAS: GNPX | ISIN: US3724461047   26/04/2024
2,210 USD (+4,25%)
(+4,25%)   26/04/2024
Grafiek Genprex Inc Grafiek Genprex Inc

Genprex Inc in het nieuws

9 april 2024 · Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting · Persbericht

3 april 2024 · Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer · Persbericht

2 april 2024 · Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System · Persbericht

22 maart 2024 · Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

19 maart 2024 · Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

19 maart 2024 · Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

12 maart 2024 · Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers · Persbericht

6 maart 2024 · Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting · Persbericht

7 februari 2024 · Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators · Persbericht

6 februari 2024 · Genprex to Present at Upcoming BIO CEO & Investor Conference · Persbericht

Profiel Genprex Inc

Fabricage van farmaceutische preparaten
Farmaceutica
Gezondheidstechnologie
Productie

Website: www.genprex.com

Hoofdzetel: Austin, Texas vlag Verenigde Staten

CEO: J. Rodney Varner

Werknemers: 26

Aandelen Genprex Inc

Beurswaarde: 4,22 miljoen USD

Effecten: 1,91 miljoen

Beta: 2,23

Mijn selecties